Related Experiment Video

Updated: May 7, 2026

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.2K

Thrombosis in pediatric cancer: identifying the risk factors to improve care

Uma Athale1

  • 1Department of Pediatrics, McMaster University, Division of Hematology/Oncology, 1280 Main Street West, Hamilton, Ontario, Canada and.

Expert Review of Hematology
|October 16, 2013
PubMed

Insights

Cancer-associated thromboembolism (TE) is a frequent complication in children with cancer, increasing mortality and morbidity. Early diagnosis and preventive anticoagulation are crucial for improving outcomes in pediatric cancer patients.

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Vascular Medicine

Background:

  • Cancer-associated thromboembolism (TE) is a significant complication in pediatric cancer patients.
  • Prevalence ranges from 16% symptomatic to 40% asymptomatic TE.
  • TE in these children increases risk of death, recurrence, and morbidity.

Purpose of the Study:

  • To highlight the importance of managing TE in pediatric cancer.
  • To emphasize the need for preventive and therapeutic strategies.
  • To underscore the significance of understanding TE risk factors in this population.

Main Methods:

  • Review of current literature on TE in pediatric cancer.
  • Analysis of prevalence data for symptomatic and asymptomatic TE.
  • Discussion of the impact of TE on patient outcomes and healthcare utilization.

Main Results:

  • Cancer-associated TE is a frequent and serious complication in children.
  • Children with cancer and TE face higher risks of adverse events compared to the general pediatric population.
  • TE is a preventable condition through anticoagulation therapy.

Conclusions:

  • Effective strategies for TE prevention, early diagnosis, and treatment are vital.
  • Understanding risk factors is key to developing targeted interventions.
  • Improving TE management is essential given high childhood cancer cure rates.

More Related Videos

A Patient-Derived Xenograft Model for Venous Malformation06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

4.5K
In Vitro Thrombosis Test for Ventricular Assist Devices09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.4K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
418
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
834
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.8K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
764
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
562